يعرض 9,321 - 9,340 نتائج من 18,343 نتيجة بحث عن 'significant ((((gap decrease) OR (((greatest decrease) OR (a decrease))))) OR (mean decrease))', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 9321
  2. 9322

    Supplementary Material for: Preliminary efficacy, tolerability, and safety analysis of Darolutamide for metastatic castration‑resistant prostate cancer: a single-center, open-label... حسب Yu J. (3610580)

    منشور في 2024
    "…The median time to PSA50 in the Darolutamide group was 1.5 months (95%CI 0.2619- 0.9545), significantly lower than that in the placebo group (3.0 months [95%CI 1.048- 3.818], p= 0.0259); The median time to PSA90 in the experimental group was 4 months (95%CI 0.3094- 1.437), 2 months shorter than that in the placebo group (6.0 months [95%CI 0.6961- 3.232]).With the median follow-up of 6 months, , the median decrease in serum PSA was -81.8% (range -60.4 to -99.9%) in the Darolutamide group and -69.4% (range -50.3 to -89.6%) in the placebo group. …"
  3. 9323

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  4. 9324

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  5. 9325

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  6. 9326

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  7. 9327

    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  8. 9328

    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  9. 9329

    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  10. 9330

    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  11. 9331

    Supplementary Material for: A comparative cross-sectional study of hair density, hair shaft diameter of different severities of anterior scalp marginal traction alopecia in women. حسب Anaba E.L. (16407435)

    منشور في 2024
    "…With increasing severity of AMTA, there was a significant decrease in HD: Grade 1 had HD of 227.56/cm2 compared to 131.22/cm2 in grade 4 at the intertemporal area, p<0.001. …"
  12. 9332

    Supplementary Figure 4 from A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer حسب Matthew T. Campbell (15096440)

    منشور في 2025
    "…<p>Flow cytometry of immune cells from serially collected blood samples with evidence of significant decrease in circulating NK cells in: A) Metastatic renal cell carcinoma cohort. …"
  13. 9333
  14. 9334

    Complementary conditioning measures in healthy subjects. حسب Gabriela Ribeiro (4748373)

    منشور في 2024
    "…<b>(I) Novelty</b> ratings significantly decreased from pre to post-conditioning (F<sub>(1,51)</sub> = 10.2, <i>P</i> = 0.002; post hoc CS<sup>-</sup>, <i>P</i> = 0.0001; post hoc CS<sup>+</sup>, <i>P</i> = 0.01) but similarly for both stimuli (F<sub>(1, 51)</sub> = 0.17, <i>P</i> = 0.7; Interaction: F<sub>(1, 51)</sub> = 1.1, <i>P</i> = 0.3). …"
  15. 9335
  16. 9336
  17. 9337

    30-year trends in incidence of acute STEMI and NSTEMI in the Belgian Province of Luxembourg. A long-term follow-up of the MONICA-BELLUX registry حسب Bernhard L. Gerber (10171583)

    منشور في 2025
    "…</p><p>b) What this study adds</p><p>In a 30-year registry in Luxembourg using modern AMI definitions, overall, AMI incidence decreased significantly, primarily due to a 3.8-fold reduction in STEMI.…"
  18. 9338

    Table 2_Promotion of physical activity-related health competence using digital workplace-based health promotion: a pilot study for office workers.docx حسب Leonard Oppermann (20639363)

    منشور في 2025
    "…The other sub-competences also increased, but not significantly. HEPA decreased after the intervention and at follow-up, but the decrease was not statistically significant.…"
  19. 9339

    Table 3_Promotion of physical activity-related health competence using digital workplace-based health promotion: a pilot study for office workers.xlsx حسب Leonard Oppermann (20639363)

    منشور في 2025
    "…The other sub-competences also increased, but not significantly. HEPA decreased after the intervention and at follow-up, but the decrease was not statistically significant.…"
  20. 9340

    Table 1_Promotion of physical activity-related health competence using digital workplace-based health promotion: a pilot study for office workers.docx حسب Leonard Oppermann (20639363)

    منشور في 2025
    "…The other sub-competences also increased, but not significantly. HEPA decreased after the intervention and at follow-up, but the decrease was not statistically significant.…"